Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Zika virus non-structural protein 1 (NS1) is a ~48-50 kDa glycoprotein essential for the flavivirus lifecycle, functioning primarily in the endoplasmic reticulum (ER) lumen where it exists as a homodimer. NS1 remodels ER membranes by inserting hydrophobic regions, such as the N-terminal β-roll and flexible loops, into the inner leaflet to induce perinuclear aggregation and form convoluted networks resembling viral replication compartments, which are critical for RNA synthesis and viral amplification. This membrane-binding and curvature-altering activity depends on specific motifs like the greasy finger and wing domains, enabling NS1 to create invaginations without direct contact with cytoplasmic replication machinery. Secreted as a hexameric lipoprotein, NS1 modulates host immune responses, interacts with glycoproteins like prM and E for virion production, and contributes to pathogenesis by evading innate immunity. Crystal structures (e.g., PDB 5K6K) reveal an elongated hydrophobic surface for membrane association and a variable polar outer face with glycosylation sites, distinguishing Zika NS1 from homologs like dengue NS1 in insertion depth and cholesterol affinity. As a validated therapeutic target, inhibiting NS1's ER remodeling or secretion could block Zika replication, though no approved drugs exist.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zika virus non-structural protein 1 (NS1) (NS1).